Clinical characteristics of subjects
| Subject . | CDC disease stage* . | CD4 count (cells/mm3) . | Plasma viremia (copies/mL) . |
|---|---|---|---|
| 136 | B2 | 410 | 4338 |
| 163 | A2 | 450 | < 500 |
| 215 | B3 | 150 | 46 322 |
| 216 | C3 | 50 | 5975 |
| 219 | A2 | 370 | 1512 |
| 237 | C2 | 260 | 3430 |
| 307 | B2 | 283 | 8633 |
| 348 | A1 | 680 | < 500 |
| 350 | A1 | 1005 | 70 |
| 351 | A1 | 571 | < 500 |
| 606 | A2 | 615 | < 50 |
| 701 | B3 | 71 | < 50 |
| 703 | A1 | 529 | < 50 |
| 704 | A1 | Unknown | < 50 |
| 705 | A2 | 650 | < 50 |
| Subject . | CDC disease stage* . | CD4 count (cells/mm3) . | Plasma viremia (copies/mL) . |
|---|---|---|---|
| 136 | B2 | 410 | 4338 |
| 163 | A2 | 450 | < 500 |
| 215 | B3 | 150 | 46 322 |
| 216 | C3 | 50 | 5975 |
| 219 | A2 | 370 | 1512 |
| 237 | C2 | 260 | 3430 |
| 307 | B2 | 283 | 8633 |
| 348 | A1 | 680 | < 500 |
| 350 | A1 | 1005 | 70 |
| 351 | A1 | 571 | < 500 |
| 606 | A2 | 615 | < 50 |
| 701 | B3 | 71 | < 50 |
| 703 | A1 | 529 | < 50 |
| 704 | A1 | Unknown | < 50 |
| 705 | A2 | 650 | < 50 |
Defined by the lowest documented CD4 count.